Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Norway
/
Healthcare
/
Medistim
MEDI
Medistim
Aging Global Populations And INTUI Upgrades Will Expand Adoption
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
03 Aug 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
NOK 260.00
0% overvalued
intrinsic discount
20 Aug
NOK 260.00
1Y
58.5%
7D
15.6%
Loading
1Y
58.5%
7D
15.6%
Author's Valuation
NOK 260.0
0% overvalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
NOK 260.0
0% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
542m
2014
2017
2020
2023
2025
2026
2028
Revenue NOK 0
Earnings NOK 0
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
7.30%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.80%
Calculation
NOK 0
Earnings '28
x
30.58x
PE Ratio '28
=
NOK 0
Market Cap '28
NOK 0
Market Cap '28
/
18.31m
No. shares '28
=
NOK 0
Share Price '28
NOK 0
Share Price '28
Discounted to 2025 @ 6.80% p.a.
=
NOK 0
Fair Value '25